Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Form 8.5 (EPT/RI) Replacement Pfizer Inc

16th May 2014 16:59

RNS Number : 3979H
Morgan Stanley Capital Services LLC
16 May 2014
 



AMENDMENT

 

 FORM 8.5 (EPT/RI)

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Morgan Stanley Capital Services LLC

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

PFIZER INC

(c) Name of the party to the offer with which exempt principal trader is connected:

 

ASTRAZENECA PLC

(d) Date dealing undertaken:

14 MAY 2014

(e) Has the EPT previously disclosed, or is it today disclosing, under the Code in respect of any other party to this offer?

Yes

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

(a) Purchases and sales

 

 Class of relevant security

 Purchases/sales

 Total number of securities

 Highest price per unit paid/received

 Lowest price per unit paid/received

 COMMON STOCK

 PURCHASES

 264,779

 29.2600 USD

 28.9400 USD

 COMMON STOCK

 SALES

 97,884

 29.2600 USD

 28.9700 USD

 

 

(b) Derivatives transactions (other than options)

 

 Class of relevant security

 Product description

e.g. CFD

 Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

 Number of reference securities

 Price per unit

 COMMON STOCK

 CFD

 LONG

 200

 29.0400 USD

 COMMON STOCK

 CFD

 LONG

 1,000

 29.0710 USD

 COMMON STOCK

 CFD

 LONG

 17,500

 29.0967 USD

 COMMON STOCK

 CFD

 LONG

 875

 29.1323 USD

 COMMON STOCK

 CFD

 LONG

 9,637

 29.1323 USD

 COMMON STOCK

 CFD

 LONG

 13

 29.1400 USD

 COMMON STOCK

 CFD

 LONG

 9

 29.1400 USD

 COMMON STOCK

 CFD

 LONG

 10

 29.1400 USD

 COMMON STOCK

 CFD

 LONG

 10

 29.1400 USD

 COMMON STOCK

 CFD

 LONG

 4

 29.1700 USD

 COMMON STOCK

 CFD

 LONG

 26

 29.1700 USD

 COMMON STOCK

 CFD

 LONG

 300

 29.1767 USD

 COMMON STOCK

 CFD

 LONG

 22,100

 29.1895 USD

 COMMON STOCK

 CFD

 LONG

 5,600

 29.2089 USD

 COMMON STOCK

 CFD

 LONG

 200

 29.2600 USD

 COMMON STOCK

 CFD

 SHORT

 1,414

 28.9695 USD

 COMMON STOCK

 CFD

 SHORT

 27

 28.9848 USD

 COMMON STOCK

 CFD

 SHORT

 178

 28.9848 USD

 COMMON STOCK

 CFD

 SHORT

 1,000

 28.9900 USD

 COMMON STOCK

 CFD

 SHORT

 30,513

 28.9985 USD

 COMMON STOCK

 CFD

 SHORT

 170

 29.0155 USD

 COMMON STOCK

 CFD

 SHORT

 5,600

 29.0233 USD

 COMMON STOCK

 CFD

 SHORT

 4,906

 29.0546 USD

 COMMON STOCK

 CFD

 SHORT

 9,000

 29.0575 USD

 COMMON STOCK

 CFD

 SHORT

 163

 29.0723 USD

 COMMON STOCK

 CFD

 SHORT

 1,803

 29.0723 USD

 COMMON STOCK

 CFD

 SHORT

 2,087

 29.0800 USD

 COMMON STOCK

 CFD

 SHORT

 1,213

 29.0800 USD

 COMMON STOCK

 CFD

 SHORT

 10,100

 29.0805 USD

 COMMON STOCK

 CFD

 SHORT

 200

 29.0925 USD

 COMMON STOCK

 CFD

 SHORT

 1

 29.1000 USD

 COMMON STOCK

 CFD

 SHORT

 7

 29.1000 USD

 COMMON STOCK

 CFD

 SHORT

 141,000

 29.1000 USD

 COMMON STOCK

 CFD

 SHORT

 2,900,000

 29.1000 USD

 COMMON STOCK

 CFD

 SHORT

 1,600

 29.1021 USD

 COMMON STOCK

 CFD

 SHORT

 38,800

 29.1049 USD

 COMMON STOCK

 CFD

 SHORT

 2,697

 29.1096 USD

 COMMON STOCK

 CFD

 SHORT

 500

 29.1599 USD

 COMMON STOCK

 CFD

 SHORT

 6,100

 29.1736 USD

 COMMON STOCK

 CFD

 SHORT

 342

 29.2139 USD

 COMMON STOCK

 CFD

 SHORT

 484

 29.2149 USD

 COMMON STOCK

 CFD

 SHORT

 532

 29.2150 USD

 COMMON STOCK

 CFD

 SHORT

 730

 29.2157 USD

 COMMON STOCK

 CFD

 SHORT

 2,400

 29.2600 USD

 

 

(c) Options transactions in respect of existing securities

 

(i) Writing, selling, purchasing or varying

 

 Class of relevant security

 Product description e.g. call option

 Writing, purchasing, selling, varying etc.

 Number of securities to which option relates

 Exercise price per unit

 Type e.g. American, European etc.

 Expiry date

 Option money paid/ received per unit

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 N/A

 

(ii) Exercising

 

 Class of relevant security

 Product description e.g. call option

 Number of securities

 Exercise price per unit

 N/A

 N/A

 N/A

 N/A

 

(d) Other dealings (including subscribing for new securities)

 

 Class of relevant security

 Nature of dealing e.g. subscription, conversion

 Details

 Price per unit (if applicable)

 N/A

 N/A

 N/A

 N/A

 

The currency of all prices and other monetary amounts should be stated.

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

None

 

 

 

 

Date of disclosure:

16 MAY 2014

Contact name:

Darren Wickert

Telephone number:

+44 (0)20 7425 6578

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at [email protected]. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
FERGGUMAAUPCGAQ

Related Shares:

AstrazenecaPFZ.L
FTSE 100 Latest
Value8,680.29
Change47.96